(Q24243570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

title

Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

N Adams

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

T J Lasserson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P W Jones

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

17 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

CD002310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Efficacy and safety of inhaled steroid and cromone treatment in school-age children: a randomized pragmatic pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Cost effectiveness of fluticasone and budesonide in patients with moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Knemometry, Urine Cortisol Excretion, and Measures of the Insulin-Like Growth Factor Axis and Collagen Turnover in Children Treated with Inhaled Glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Adrenal function and high dose inhaled corticosteroids for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Stepping down inhaled corticosteroids in asthma: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Beclomethasone at different doses for chronic asthma (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

An in vitro comparison of commonly used topical glucocorticoid preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

Inhaled fluticasone at different doses for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002310.PUB4

7 January 2021

10.1002/14651858.CD002310.PUB4

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17943772%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017